Sound Shore Management »

Regeneron Pharmaceuticals shares owned by Sound Shore Management

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Sound Shore Management from 13F filings

Historical chart of Sound Shore Management investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Sound Shore Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Sound Shore Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $136M 176k 771.87
2025-09-30 $65M 115k 562.27

More positions owned by Sound Shore Management

Regeneron Pharmaceuticals Common (REGN)
Teva Pharmaceutical Industries Common (TEVA)
Alphabet Inc. Cl A Common (GOOGL)
Public Service Enterprise Common (PEG)
Walt Disney Company Common (DIS)
Berkshire Hathaway, Inc. C Common (BRK.B)
Southwest Airlines Common (LUV)
QUALCOMM Incorporated Common (QCOM)
Salesforce Common (CRM)
AES Corporation Common (AES)
Kinder Morgan Common (KMI)
Citigroup Common (C)
Fidelity National Information Services Common (FIS)
Incyte Corporation Common (INCY)
Capital One Financial Corp Common (COF)

View all positions for Sound Shore Management

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
State Street Corporation
Dodge & Cox
Jpmorgan Chase & Co
Franklin Resources
Geode Capital Management
Nuveen
FMR
Loomis, Sayles and
Invesco
Capital World Investors
Susquehanna International
Goldman Sachs Group
Norges Bank Investment Management

View all funds holding Regeneron Pharmaceuticals